Midazolam Infusion for Pediatric Refractory Status Epilepticus
For pediatric refractory status epilepticus (RSE), administer midazolam with a loading dose of 0.15-0.20 mg/kg IV, followed by continuous infusion starting at 1 mcg/kg/min (0.06 mg/kg/hr), titrating upward by 1 mcg/kg/min increments every 15 minutes until seizures stop, with a maximum of 5 mcg/kg/min (0.3 mg/kg/hr). 1
Dosing Algorithm
Loading Dose
- Initial bolus: 0.15-0.20 mg/kg IV over 2-3 minutes 1
- This establishes therapeutic levels rapidly before starting the infusion
Continuous Infusion Protocol
- Starting rate: 1 mcg/kg/min (0.06 mg/kg/hr) 1
- Titration: Increase by 1 mcg/kg/min every 15 minutes until seizures cease 1
- Maximum rate: 5 mcg/kg/min (0.3 mg/kg/hr) 1
Critical Timing Considerations
Early administration is crucial. Recent evidence demonstrates that low-dose midazolam infusion (<0.2 mg/kg/hr) administered early—after only a single benzodiazepine dose or one antiseizure medication—achieves seizure cessation in 59% of cases 2. However, when midazolam is delayed until after multiple failed medications, effectiveness drops dramatically to 37%, even at higher doses 2.
Do not delay beyond 500 mcg/kg/hr (0.5 mg/kg/hr). Data shows diminishing returns above this threshold, with patients spending a median of 3.8 hours titrating in this ineffective range before requiring escalation to pentobarbital 3. If seizures persist despite reaching 500 mcg/kg/hr, consider transitioning to alternative therapy rather than continuing to escalate midazolam.
Essential Monitoring Requirements
Respiratory Support
- Prepare for intubation: There is an increased incidence of apnea when midazolam is combined with other sedative agents 1
- Continuous oxygen saturation monitoring is mandatory 1
- Have airway equipment immediately available
- Most patients at these doses will require mechanical ventilation
Hemodynamic Monitoring
Hypotension is common and dose-dependent. In a recent study, 67.9% of patients receiving continuous midazolam for RSE developed hemodynamic compromise requiring vasopressor initiation or escalation 4. Patients who developed hypotension received higher mean maximum doses (0.88 mg/kg/hr vs 0.55 mg/kg/hr) and longer treatment durations (2.5 days vs 1.5 days) 4.
- Establish arterial line for continuous blood pressure monitoring
- Have vasopressors readily available
- Ensure adequate IV access before initiating therapy
EEG Monitoring
- Continuous EEG is essential to confirm seizure cessation and guide titration 5
- Clinical seizure cessation does not guarantee electrographic control
- Target either burst-suppression pattern or complete seizure suppression 5
Important Clinical Caveats
Age-Specific Considerations
- Infants <6 months: Use extreme caution with smaller incremental doses and careful monitoring due to vulnerability to airway obstruction and hypoventilation 6
- Younger children (<6 years): Generally require higher mg/kg doses than older children 6
Drug Interactions
When midazolam is combined with opioids or other CNS depressants, the risk of respiratory depression, airway obstruction, and hypoventilation increases substantially 1, 6. Reduce initial doses by 50% or more if the patient has received recent opioids or sedatives.
Reversal Agent Warning
Do not use flumazenil routinely. While flumazenil can reverse midazolam-induced respiratory depression, it will also reverse anticonvulsant effects and may precipitate seizure recurrence 1. Reserve for life-threatening respiratory depression only when mechanical ventilation is not immediately available.
Treatment Failure Threshold
If seizures persist after reaching 5 mcg/kg/min (0.3 mg/kg/hr), this represents treatment failure. At this point, transition to alternative therapy such as pentobarbital, propofol, or ketamine rather than continuing to escalate midazolam 5. The evidence suggests that doses above 500 mcg/kg/hr (0.5 mg/kg/hr) are associated with diminishing frequency of seizure cessation 3, and continuing to titrate in this range delays definitive treatment.
Duration and Weaning
Once seizures are controlled for 12-24 hours, begin gradual weaning by decreasing the infusion rate by 10-25% every few hours to find the minimum effective rate 6. Abrupt discontinuation should be avoided as it may precipitate seizure recurrence. One study reported only 6% relapse rate with gradual weaning 7.